ストックスクリーナーアプリを入手
30.14
3.74%
-1.17
アフターアワーズ：
30.16
0.02
+0.07%
前日終値:
$31.31
開ける：
$30.99
24時間の取引高:
626.78K
Relative Volume:
0.57
時価総額：
$33.25B
収益：
$418.33M
当期純損益:
$-252.07M
株価収益率:
-12.56
EPS:
-2.4
ネットキャッシュフロー:
$-238.84M
1週間 パフォーマンス:
-3.77%
1か月 パフォーマンス:
-5.34%
6か月 パフォーマンス:
+4.47%
1年 パフォーマンス:
+65.70%
1日の値動き範囲:
$29.82
$31.20
1週間の範囲:
$29.82
$31.34
52週間の値動き範囲:
$16.01
$39.77
Zai Lab Limited Adr Stock (ZLAB) Company Profile
ZLAB を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ZLAB
Zai Lab Limited Adr
|
30.14 | 3.43B | 418.33M | -252.07M | -238.84M | -2.40 |
|
ONC
Beone Medicines Ltd Adr
|
245.58 | 26.10B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
442.05 | 111.96B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.35 | 42.96M | 0 | 0 | 0 | 0.00 |
|
VRNA
Verona Pharma Plc Adr
|
81.20 | 6.39B | 0 | -153.72M | -103.81M | -2.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
490.28 | 63.52B | 14.09B | 4.50B | 2.96B | 39.28 |
Zai Lab Limited Adr Stock (ZLAB) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-03-07 | 開始されました | Scotiabank | Sector Outperform |
| 2025-03-03 | ダウングレード | BofA Securities | Buy → Neutral |
| 2023-12-14 | 開始されました | Morgan Stanley | Overweight |
| 2023-08-10 | 開始されました | Cantor Fitzgerald | Overweight |
| 2022-01-21 | 開始されました | Macquarie | Outperform |
| 2021-10-12 | 開始されました | Bernstein | Mkt Perform |
| 2020-04-28 | 開始されました | Goldman | Buy |
| 2020-04-15 | 開始されました | Guggenheim | Buy |
| 2019-07-12 | 開始されました | BofA/Merrill | Buy |
| 2019-07-05 | 開始されました | Macquarie | Outperform |
| 2019-01-29 | 開始されました | Credit Suisse | Outperform |
| 2018-11-21 | 開始されました | Jefferies | Buy |
| 2018-06-21 | 再開されました | Leerink Partners | Outperform |
| 2018-02-14 | アップグレード | JP Morgan | Neutral → Overweight |
| 2017-10-16 | 開始されました | JP Morgan | Neutral |
| 2017-10-16 | 開始されました | Leerink Partners | Outperform |
すべてを表示
Zai Lab Limited Adr (ZLAB) 最新ニュース
Zai Lab Lines Up Triple Conference Presence: Jefferies, Goldman Sachs, and Scotiabank Healthcare Events - Stock Titan
Zai Lab Announces Participation in Investor Conferences in June 2025 - Business Wire
Northern Trust Corp Increases Holdings in Zai Lab Limited (NASDAQ:ZLAB) - Defense World
Quantinno Capital Management LP Reduces Position in Zai Lab Limited (NASDAQ:ZLAB) - Defense World
BNP Paribas Financial Markets Purchases 18,472 Shares of Zai Lab Limited (NASDAQ:ZLAB) - Defense World
Zai Lab Receives U.S. FDA Fast Track Designation for ZL-1310, a DLL3-Targeted Antibody-Drug Conjugate, for Treatment of Extensive-Stage Small Cell Lung Cancer - BioSpace
Barclays PLC Boosts Stake in Zai Lab Limited (NASDAQ:ZLAB) - Defense World
Cantor Fitzgerald Expects Increased Earnings for Zai Lab - Defense World
Zai Lab Limited (NASDAQ:ZLAB) Q1 2025 Earnings Call Transcript - Insider Monkey
Zai Lab Limited (ZLAB) Reports Q1 Earnings: What Key Metrics Have to Say - MSN
Decoding Zai Lab Ltd (ZLAB): A Strategic SWOT Insight - GuruFocus
Trading Day Triumph: Zai Lab Limited ADR (ZLAB) Ends at 29.38, a -5.07 Surge/Plunge - DWinneX
Raymond James Financial Inc. Makes New $1.03 Million Investment in Zai Lab Limited (NASDAQ:ZLAB) - Defense World
Zai Lab Limited (NASDAQ:ZLAB) Shares Bought by Invesco Ltd. - Defense World
Envestnet Asset Management Inc. Buys New Shares in Zai Lab Limited (NASDAQ:ZLAB) - Defense World
Geode Capital Management LLC Boosts Position in Zai Lab Limited (NASDAQ:ZLAB) - Defense World
Post-Trade Analysis: VICI Properties Inc (VICI) Climbs 0.06, Closing at 32.26 - DWinneX
Market Insights: Canadian Solar Inc (CSIQ)’s Notable Drop of -1.73, Closing at 9.65 - DWinneX
Daily Market Movement: Faraday Future Intelligent Electric Inc (FFAI) Sees a -0.76 Decrease, Closing at 1.30 - DWinneX
In the Green: Zai Lab Limited ADR (ZLAB) Closes at 31.84, Up/Down -1.82 from Previous Day - DWinneX
Closing Bell Recap: C.H. Robinson Worldwide, Inc (CHRW) Ends at 88.33, Reflecting a -0.84 Downturn - DWinneX
Zai Lab Limited ADR (ZLAB) is looking forward to a strong quarter - Sete News
Wells Fargo & Company MN Grows Stake in Zai Lab Limited (NASDAQ:ZLAB) - Defense World
Zai Lab Ltd Announces 2025 Annual General Meeting - TipRanks
Zai Lab Limited ADR (ZLAB) is an excellent investment, but the stock is overvalued/undervalued right now - uspostnews.com
Zai Lab Presents Data Highlighting Potential of Internally Developed, Next-Generation Oncology Therapies at AACR 2025 - Business Wire
Ratios Reveal: Breaking Down Packaging Corp Of America (PKG)’s Financial Health - DWinneX
Analytical Overview: GE Vernova Inc (GEV)’s Ratios Tell a Financial Story - DWinneX
Financial Health Check: Examining Bellring Brands Inc (BRBR)’s Key Ratios - DWinneX
Deeper Dive: Understanding Concentrix Corp (CNXC) Through its Various Ratios - DWinneX
A stock that deserves closer examination: Zai Lab Limited ADR (ZLAB) - uspostnews.com
Analytical Overview: Erasca Inc (ERAS)’s Ratios Tell a Financial Story - DWinneX
Ratios Reveal: Breaking Down Check Point Software Technologies Ltd (CHKP)’s Financial Health - DWinneX
Financial Metrics Unveiled: Orchestra BioMed Holdings Inc (OBIO)’s Key Ratios in the Spotlight - DWinneX
Ratios in Focus: Analyzing Watsco Inc (WSO)’s Price-to-Cash and Price-to-Free Cash Flow - DWinneX
Theratechnologies Inc (THTX)’s Ratio Roundup: Key Metrics for Trailing Twelve Months - DWinneX
Financial Health Check: Examining Astronics Corp (ATRO)’s Key Ratios - DWinneX
Zai Lab Limited (NASDAQ:ZLAB) Shares Acquired by Bank of Montreal Can - Defense World
Zai Lab to Present Data from Phase 1 Trial of DLL3-Targeted Antibody-Drug Conjugate (ADC) ZL-1310 at 2025 ASCO Annual Meeting - Business Wire
Zai Lab Limited (NASDAQ:ZLAB) Position Boosted by Renaissance Technologies LLC - Defense World
Equitable Holdings Inc [EQH] Insider Lane Nick sells 5,000 Shares – Company Insider Activity - knoxdaily.com
Palantir Technologies Inc [PLTR] Insider Stat Lauren Elaina Friedman sells 800 Shares for $800 - knoxdaily.com
Zai Lab Limited ADR [ZLAB] Insider Smiley Joshua L sells 3,354 Shares – Latest News - knoxdaily.com
Zai Lab Announces Acceptance of Supplemental New Drug Application for Repotrectinib for Patients with NTRK-Positive Solid Tumors - Business Wire
JPMorgan Chase & Co. Buys 23,510 Shares of Zai Lab Limited (NASDAQ:ZLAB) - Defense World
All You Need to Know About Zai Lab Limited (ZLAB) Rating Upgrade to Buy - Yahoo Finance
Zai Lab Limited (ZLAB) Moves 21.5% Higher: Will This Strength Last? - MSN
Zai Lab to Announce First Quarter 2025 Financial Results and Recent Corporate Updates on May 8, 2025 - Yahoo Finance
Zai Lab (NASDAQ:ZLAB) Shares Gap Up – Should You Buy? - Defense World
Asian ADRs Shine As Zai Lab And CNFinance Lead The Gains - Finimize
Zai Lab Limited Adr (ZLAB) 財務データ
収益
当期純利益
現金流量
EPS
1.32%
1.89%
大文字化:
|
ボリューム (24 時間):